Combogesic® IV (acetaminophen/ibuprofen) – New drug approval
October 18, 2023 - Hyloris Pharmaceuticals announced the FDA approval of Combogesic IV (acetaminophen/ibuprofen), in adults where an intravenous (IV) route of administration is considered clinically necessary for the relief of mild to moderate pain or the management of moderate to severe pain as an adjunct to opioid analgesics.
Top